Target intelligence / Profile preview

Olfactory receptor family 1 subfamily J member 2 (OR1J2)

Target
OR1J2
Molecular classification
G protein-coupled receptor (GPCR), Receptor, 7-transmembrane protein
01

Overview

Olfactory receptor family 1 subfamily J member 2 (OR1J2) is a protein-coding gene encoding a member of the olfactory receptor family, which belongs to the class A G protein-coupled receptor (GPCR) superfamily[3][5]. OR1J2 shares a seven-transmembrane domain architecture characteristic of GPCRs and is responsible for recognizing odorant molecules in the nasal epithelium, thereby initiating a neuronal response that enables the sense of smell[3][5]. The gene is part of the largest gene family in the human genome. It is closely related to other OR1J family members (e.g., OR1J3, OR1J5) but is a distinct molecular entity, with some historical synonyms arising from gene reannotation and paralog confusion. While its primary function is in olfaction, emerging research indicates olfactory receptors may be involved in nonolfactory physiological functions in extranasal tissues (e.g., brain, pancreas, testes), suggesting possible roles in disease that remain under investigation[5]. Currently, there is no clinical evidence of direct drug targeting, safety concerns, or biomarker utility for OR1J2.

Other names
OR1J2Olfactory receptor 1J2OR1J3OR1J5OST044HTPCRX15OR9-19HG152HSA5
02

Mechanism of action

Ligand (odorant) binding activates the receptor, triggering G protein-mediated signal transduction, leading to neuronal signaling. No known drugs with a therapeutic mechanism of action targeting OR1J2; all mechanisms described are physiological.

03

Biological functions

Odorant recognitionG protein-mediated signal transductionInitiates neuronal response for smell perceptionExtranasal signaling (brain, pancreas, testes)
04

Disease associations

Cataract 21, multiple types (association)Arthrogryposis multiplex congenita 2, neurogenic type (association)Emerging: Dysregulation in extranasal tissues (brain, pancreas, testes) may implicate ORs in disease mechanisms, though specific data for OR1J2 remains limited
05

Safety considerations

None directly reported. As OR1J2 is primarily involved in sensory perception, safety concerns for direct targeting are largely theoretical. For the olfactory receptor family, extranasal expression raises possible uncharacterized effects if targeted by systemic drugs.

Beyond the preview

Go deeper on Olfactory receptor family 1 subfamily J member 2 (OR1J2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olfactory receptor family 1 subfamily J member 2 (OR1J2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call